Pharmanews January-February 2020 update
2.pharmacy times headlines
3.Pharma guild lines
4.Fierce pharma blogposts
Important points:
1.PTC has filed its gene therapy to treat aromatic amino acid decarboxylase deficiency (AADC) due to mutation in dopa decarboxylase .Its arare disease seen in children.
2.fluoxetine to be used for neuroblastoma achildhood cancer which stabilizes the gene CDN1B.
3.Eli Lilly to buy dermira for $1.1billion .it is used i atopic dermatitis. It is currently in phase3 trials.
4.FDA summon market withdrawal of Belviq due ton cancer risk
5.Newer antibodies found against coronavirus in india.
6. FDA turns out 3 drugs from Rx to OTC ie olapatadine(conjunctivitis)0.2% and 0.1 % voltaren( arthritis) .
7.Antihistamines to affect your driving abilities. alert by fda .
8.Benzocaine not good for childrwn below 2 year used for tooth pain .
9.Novartis plan to use inclisiran for cvs disorder and atherosclerosis.
10.UK based Exscientia uses cetaur chemist AI technology for drug discovery for cancer, CVS diseases ,collaborate with Bayer .
thankyou , please subscribe
2.fluoxetine to be used for neuroblastoma achildhood cancer which stabilizes the gene CDN1B.
3.Eli Lilly to buy dermira for $1.1billion .it is used i atopic dermatitis. It is currently in phase3 trials.
4.FDA summon market withdrawal of Belviq due ton cancer risk
5.Newer antibodies found against coronavirus in india.
6. FDA turns out 3 drugs from Rx to OTC ie olapatadine(conjunctivitis)0.2% and 0.1 % voltaren( arthritis) .
7.Antihistamines to affect your driving abilities. alert by fda .
8.Benzocaine not good for childrwn below 2 year used for tooth pain .
9.Novartis plan to use inclisiran for cvs disorder and atherosclerosis.
10.UK based Exscientia uses cetaur chemist AI technology for drug discovery for cancer, CVS diseases ,collaborate with Bayer .
thankyou , please subscribe
Comments
Post a Comment